A Double Blind Placebo Controlled Crossover Study in Subjects with Cerebral Palsy to Evaluate the Safety and Tolerability and the Effect on Sensorim
Keyword(s):
Study, Research, Cerebral Palsy, Dalfampridine, Safety
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Quality Assurance, Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Adults with Disabilities
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
State
COVID-19 Related Data:
N/A